White House to hold a listening session on reforming pharmacy benefit managers; A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

Taking stock of the drug industry, from the lab to the medicine chest

February 28, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | White House to hold a listening session on reforming pharmacy benefit managers Government and industry leaders will discuss how pharmacy benefit managers determine which medicines are covered, how prices are set, in Monday meeting. By Ed Silverman STAT+ | A 'renaissance in neuroscience' could deliver a fresh crop of psychiatric medicines The drug industry has renewed its interest in neuroscience with new treatments in the works for schizophrenia, bipolar disorder, and depression. By Damian Garde Cholera vaccine shortage reaches worst point yet, with experts fearing deadly outbreaks Two-dose cholera vaccine reduced to a single dose, yet demand still far outstrips supply. Outbreaks currently reported in 16 countries. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser